(Q22252801)

Dimensions

6 February 2023

Martin Storr

2

Martin

Storr

1 reference

Dimensions

1044898925

6 February 2023

Beat Lutz

series ordinal

3

author given names

Beat

author last names

Lutz

1 reference

Dimensions

1044898925

Journal of Molecular Medicine

6 February 2023

language of work or name

English

0 references

publication date

26 August 2005

0 references

published in

0 references

volume

83

0 references

issue

12

0 references

page(s)

944-954

0 references

cites work

The evidence for the existence of cannabinoid receptors.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-005-0698-5

Differential roles of CB1 and CB2 cannabinoid receptors in mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-005-0698-5

Role of endogenous cannabinoids in synaptic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-005-0698-5

Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-005-0698-5

Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-005-0698-5

Cannabinoids and cancer: causation, remediation, and palliation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-005-0698-5

Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxations and reflux in dogs.

21 January 2018

1 reference

12 December 2020

Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus

1 reference

12 December 2020

Tetrahydrocannabinol‐induced neurotoxicity depends on CB1 receptor‐mediated c‐Jun N‐terminal kinase activation in cultured cortical neurons

1 reference

12 December 2020

The endogenous cannabinoid system protects against colonic inflammation

1 reference

12 December 2020

Gastrointestinal hormones and food intake

1 reference

12 December 2020

Endogenous cannabinoid system as a modulator of food intake

1 reference

12 December 2020

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

1 reference

12 December 2020

In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum

1 reference

12 December 2020

Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1.

1 reference

12 December 2020

Gastrointestinal afferents as targets of novel drugs for the treatment of functional bowel disorders and visceral pain

1 reference

12 December 2020

LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation

1 reference

12 December 2020

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

1 reference

12 December 2020

CB(1) and CB(2) receptor-mediated signalling: a focus on endocannabinoids

1 reference

12 December 2020

Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?

1 reference

12 December 2020

Brain monoglyceride lipase participating in endocannabinoid inactivation

1 reference

12 December 2020

Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin.

1 reference

12 December 2020

Pharmacology of cannabinoid CB1 and CB2 receptors.

1 reference

12 December 2020

Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1).

1 reference

12 December 2020

Imaging the brain marijuana receptor: development of a radioligand that binds to cannabinoid CB1 receptors in vivo.

1 reference

12 December 2020

Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors

1 reference

12 December 2020

Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro

1 reference

12 December 2020

Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats

1 reference

12 December 2020

SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.

1 reference

12 December 2020

Cannabinoid receptors differentially modulate potassium A and D currents in hippocampal neurons in culture

1 reference

12 December 2020

Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract.

1 reference

12 December 2020

Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons.

1 reference

12 December 2020

Cannabinoid/opioid crosstalk in the central nervous system

1 reference

12 December 2020

Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors

1 reference

12 December 2020

Fatty acid amide hydrolase controls mouse intestinal motility in vivo

1 reference

12 December 2020

The endocannabinoid system and the molecular basis of paralytic ileus in mice

1 reference

12 December 2020

Pharmacology of cannabinoid receptor ligands.

1 reference

12 December 2020

Effect of vanilloid drugs on gastrointestinal transit in mice

1 reference

12 December 2020

Cannabinoid1 receptor in the dorsal vagal complex modulates lower oesophageal sphincter relaxation in ferrets

1 reference

12 December 2020

Possible endocannabinoid control of colorectal cancer growth

1 reference

12 December 2020

Cannabinoid receptors and their ligands

1 reference

12 December 2020

Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice

1 reference

12 December 2020

The endocannabinoid nervous system: unique opportunities for therapeutic intervention

1 reference

12 December 2020

Cannabinoids for gastrointestinal diseases: potential therapeutic applications

1 reference

12 December 2020

Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.

1 reference

12 December 2020

Endocannabinoids as physiological regulators of colonic propulsion in mice

1 reference

12 December 2020

Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs.

1 reference

12 December 2020

Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle

1 reference

12 December 2020

Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals.

1 reference

12 December 2020

Systemic pharmacomodulation of transient lower esophageal sphincter relaxations

1 reference

12 December 2020

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

12 December 2020

Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice

1 reference

12 December 2020

Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents.

1 reference

12 December 2020

Cannabinoid CB1-mediated inhibition of stress-induced gastric ulcers in rats

1 reference

12 December 2020

Delta9-tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB1 receptors.

1 reference

12 December 2020

Localisation of cannabinoid CB(1) receptor immunoreactivity in the guinea pig and rat myenteric plexus

1 reference

12 December 2020

The central and peripheral effects of delta-9-tetrahydrocannabinol on gastrointestinal transit in mice.

1 reference

12 December 2020

Localization of CB1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system

1 reference

12 December 2020

Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1)

1 reference

12 December 2020

Endocannabinoids and the gut.

1 reference

12 December 2020

Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630

1 reference

12 December 2020

Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review

1 reference

12 December 2020

Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study

1 reference

12 December 2020

Cannabis, hypochlorhydria, and cholera

1 reference

12 December 2020

The molecular logic of endocannabinoid signalling

1 reference

12 December 2020

Cannabinoids and the gastrointestinal tract

1 reference

12 December 2020

The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt

1 reference

12 December 2020

Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis

1 reference

12 December 2020

Evidence that cannabinoid-induced inhibition of electrically evoked contractions of the myenteric plexus--longitudinal muscle preparation of guinea-pig small intestine can be modulated by Ca2+ and cAMP.

1 reference

12 December 2020

Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors

1 reference

12 December 2020

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor

1 reference

12 December 2020

The endocannabinoid system and its therapeutic exploitation

1 reference

12 December 2020

Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus.

1 reference

12 December 2020

Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist

1 reference

12 December 2020

1 reference

12 December 2020

Synthesis, biological properties, and molecular modeling investigations of novel 3,4-diarylpyrazolines as potent and selective CB(1) cannabinoid receptor antagonists

1 reference

12 December 2020

Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation

1 reference

12 December 2020

Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon

1 reference

12 December 2020

Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach

1 reference

12 December 2020

Active bicarbonate-dependent secretion evoked by 5-hydroxytryptamine in porcine ileal mucosa is mediated by opioid-sensitive enteric neurons

1 reference

12 December 2020

Inhibitory effect of cannabinoid agonists on gastric emptying in the rat

1 reference

12 December 2020

The gastrointestinal pharmacology of cannabinoids: an update.

1 reference

12 December 2020

A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

1 reference

12 December 2020

Cannabinoids and intestinal motility: welcome to CB2 receptors

1 reference

12 December 2020

Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development

1 reference

12 December 2020

Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret

1 reference

12 December 2020

SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization

1 reference

12 December 2020

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

1 reference

12 December 2020

Inhibition of histamine-stimulated gastric acid secretion by Δ9-tetrahydrocannabinol in rat isolated stomach

1 reference

12 December 2020

Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS

1 reference

12 December 2020

Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus

1 reference

12 December 2020

Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.

1 reference

12 December 2020

AM630, a competitive cannabinoid receptor antagonist

1 reference

12 December 2020

Opioid, cannabinoid and vanilloid receptor localization on porcine cultured myenteric neurons

1 reference

12 December 2020

Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats

1 reference

12 December 2020

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

1 reference

12 December 2020

The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1.

1 reference

12 December 2020

An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice

1 reference

12 December 2020

123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors.

1 reference

12 December 2020

Inhibitory effect of the cannabinoid receptor agonist WIN 55,212-2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat.

1 reference

12 December 2020

Cannabinoid modulation of peripheral autonomic and sensory neurotransmission

1 reference

12 December 2020

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

1 reference

12 December 2020

Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations

1 reference

12 December 2020

Role of cannabinoid CB1 receptors and tumor necrosis factor-alpha in the gut and systemic anti-inflammatory activity of SR 141716 (rimonabant) in rodents

1 reference

12 December 2020

10.1007/S00109-005-0698-5

Identifiers

DOI

0 references